Owl's Brew
Series A in 2021
Owl's Brew, founded in 2013 by tea sommelier Jennie Ripps and Maria Littlefield, specializes in all-natural, loose leaf tea blends crafted in New York City. The company offers two primary product lines: Owl's Brew Mixer, a selection of tea-based craft cocktail mixers, and Owl's Brew Boozy Tea, which combines brewed tea with alcohol. The beverages are made from whole tea leaves, fruits, spices, and herbs, ensuring that no artificial flavors are added. This commitment to quality allows consumers to enjoy a variety of flavored tea products that are both refreshing and unique.
Imbed Biosciences
Series A in 2019
Imbed Biosciences, Inc. is a privately held medical device company based in Madison, Wisconsin, that specializes in developing innovative technologies for embedding bioactive molecules in wound dressings and surgical implants. The company focuses on creating antibacterial silver nanofilms that facilitate the sustained release of non-toxic silver in wounds, thereby preventing infections and promoting faster healing. Imbed’s advancements aim to address the significant market for managing surgical and chronic wounds, valued at approximately $3 billion in the U.S. and Europe. As a spin-off from the University of Wisconsin-Madison, Imbed benefits from four years of research conducted by a multidisciplinary team of engineers, veterinary scientists, and medical surgeons, collectively bringing over 25 years of expertise in clinical wound management.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.